Riskpilot← Back to searchSign inGet full accessEQUIDAN VETLINE ApS
APSActiveCVR 27927106Baggeskærvej 56Other specialised wholesale n.e.c. · NACE 4689Est. 200413 employees
Revenue 2025
DKK 13,3M
+15% vs 2024
EBITDA margin
52.5%
+21% vs 2024
Equity ratio
68.2%
Financial strength
Net profit 2025
DKK 5,2M
+19% vs 2024
| Revenue | DKK 13,3M | +15% |
| EBITDA | DKK 7M | +21% |
| Net profit | DKK 5,2M | +19% |
| Total assets | DKK 10,9M | -19% |
| Equity | DKK 7,4M | +19% |
| Employees | 13 | — |
Legal name
EQUIDAN VETLINE ApS
CVR number
27927106
Legal form
Anpartsselskab
NACE code
4689 · Other specialised wholesale n.e.c.
Founded
1. juli 2004
Share capital
DKK 250.000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er produktion, salg og handel med produkter til veterinærbranchen samt anden virksomheder, der står i naturlig forbindelse hermed.
Address
Baggeskærvej 56
Phone
+4596814000
Email
info@equidan.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 11.257 | 11.331 | 12.189 | 11.490 | 13.256 |
| Staff expenses | -5.941 | -5.655 | -6.291 | -5.719 | -6.299 |
| EBITDA | 5.317 | 5.677 | 5.897 | 5.772 | 6.957 |
| Depreciation & amort. | -242 | -311 | -342 | -245 | -317 |
| EBIT | 5.075 | 5.366 | 5.555 | 5.527 | 6.641 |
| Net financials | 467 | 107 | 121 | 37 | 9 |
| Profit before tax | 5.542 | 5.472 | 5.677 | 5.563 | 6.650 |
| Tax | 1.220 | 1.205 | 1.269 | 1.227 | 1.471 |
| Net profit | 4.322 | 4.267 | 4.407 | 4.336 | 5.179 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 10.470 | 12.208 | 14.949 | 13.463 | 10.900 |
| Equity | 7.806 | 7.573 | 8.080 | 6.256 | 7.435 |
| Long-term debt | 40 | 33 | 50 | 0 | 0 |
| Short-term debt | 2.624 | 4.602 | 6.819 | 7.180 | 3.434 |
| Total debt | 2.664 | 4.635 | 6.869 | 7.180 | 3.434 |
EBITDA margin
52.5%
This company
15.8%
Market median
+232% vs market
20212025
Equity ratio
68.2%
This company
38.2%
Market median
+79% vs market
20212025
Return on equity
69.7%
This company
18.4%
Market median
+279% vs market
20212025
Net profit margin
39.1%
This company
8.1%
Market median
+383% vs market
20212025
Asset turnover
1.22×
This company
1.12×
Market median
+9% vs market
20212025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CG Management | Management | 2004 |
JB Management | Management | 2004 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
B&S 04. 08. 2006 Holding ApS
EQUIDAN VETLINE ApS Board members of EQUIDAN VETLINE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlotte Grønbæk Baymler Sørensen | Management | 0 companies |
| Jørgen Baymler | Management | 0 companies |